Liposomal Hemorrhoid Master
Product Images NDC 63742-022

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Liposomal Hemorrhoid Master (NDC 63742-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Resolution Laboratory, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (Image 1)

Image Description (Image 1)
This text appears to be the description of a hemorrhoid treatment product. The product contains 6.45% lidocaine and 0.25% phenylephrine HCI. It is a hemorrhoidal ointment that provides temporary relief of pain, burning, and soreness associated with hemorrhoids. It also temporarily shrinks hemorrhoidal tissue and reduces swelling caused by irritation. The ointment is enhanced with witch hazel, Vitamin B6, frankincense, chamomile, and coconut oil. The packaging is child-resistant. The directions for use include applying the ointment to the affected area. The text also includes some warnings and precautions regarding the product's usage.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.